Federal Commission Proposes Sweeping Changes to U.S. Research Funding Washington D.C. – A national commission has issued a comprehensive report advocating for …
pharmaceuticals
-
-
FDA Drug Approval Process Under Scrutiny: Leadership Intervention Raises Concerns Washington – A recent shift in the Food and Drug Administration’s (FDA) …
-
CDC Reverses Position on Vaccine-Autism Link, Sparking Controversy WASHINGTON – In a stunning and unexpected move, the Centers for Disease Control and …
-
Pfizer and Tris Pharma Settle Texas Lawsuit Over ADHD Drug Manufacturing Concerns for $41.5 Million Pharmaceutical giants Pfizer and Tris Pharma have …
-
Rising Antibiotic Resistance: A Global Threat Demands Urgent Action The escalating crisis of antibiotic resistance is rapidly eroding our ability to treat …
-
Trump Administration Announces Lower GLP-1 Drug Prices for Medicare, Medicaid, and TrumpRx Users February 29, 2024 Washington D.C. – In a move …
-
Pfizer Sues Novo Nordisk in Escalating Battle for Metsera In a dramatic turn of events, Pfizer initiated legal action against Novo Nordisk …
-
Moderna’s CMV Vaccine Faces Setback in Late-Stage Trial Cambridge, Massachusetts – Moderna experienced a significant hurdle Wednesday as its experimental vaccine designed …
-
Washington D.C. – A recent analysis by the Congressional Budget Office (CBO) reveals the “One Big Beautiful Bill Act” is projected to …
-
FDA Slowdown: Drug Approvals Decline as Agency Faces Internal Challenges A recent analysis indicates a notable shift in the operational tempo of …